Raymond James Rates Healthcare Realty Trust (HR) buy

Raymond James raised its rating on Healthcare Realty Trust, setting a new price target, a 19.05% upside from the current price.

By EarningsIQ Research Desk · Published Jun 17, 2026, 10:00 AM EDT · Updated Jun 23, 2026, 1:02 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Raymond James rated Healthcare Realty Trust Incorporated ($HR) "buy" with a $24 price target on June 17, 2026.

Since the rating, $HR is up 2.0% after 1 week, up 6.5% after 1 month and down 11.6% to date (from the $19.78 close on Jun 17, 2026).

HR Healthcare Realty Trust Incorporated

$17.48 +7.04% year to date

Daily close · Oct 16, 2026

Key Points

Raymond James reinstated a 'buy' rating on Healthcare Realty Trust with a $24 price target on June 17, 2026.
Raymond James's $24 price target implies 19.05% upside from Healthcare Realty Trust Incorporated's ($HR) current $20.16 share price.
Healthcare Realty Trust's stock, trading at $20.50, has a market cap of about $7.1 billion and a 52-week high of $20.90.
Recent insider buying includes multiple directors purchasing shares at $20.20, while CEO Peter Scott sold shares in April.

Get $HR trade alerts by text

We text you when insiders, Congress or big funds trade $HR. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Healthcare Realty Trust Incorporated alert may contain errors. Disclosures

Raymond James has upgraded Healthcare Realty Trust Incorporated (NYSE:HR) to a 'buy' rating with a price target of $24. Analyst David Rodgers made the call on June 17, 2026, as the stock traded around $20.50.

Analysts Set New Price Targets

On June 17, 2026, Raymond James reinstated its 'buy' rating for Healthcare Realty Trust, setting a price target of $24. This upgrade reflects a positive outlook for the company's stock. Other analysts have also weighed in recently: Wells Fargo maintained a 'hold' rating with a $21 target on June 1, while Scotiabank maintained a 'buy' rating with a $22 target on May 8. Overall, the consensus from 11 analyst opinions remains a 'hold', with an average target price of approximately $20.82.

Other Institutional Activity in Healthcare Realty Trust

Several institutional investors have adjusted their positions in Healthcare Realty Trust. BlackRock, Inc. increased its holdings by 1,228,380 shares, ending with 54,844,563 shares valued at about $931.8 million. Cohen & Steers, Inc. reduced its stake by 3,858,978 shares, now holding 52,446,482 shares worth approximately $891.1 million. Vanguard Portfolio Management LLC established a new position with 28,623,399 shares valued at $486.3 million. Meanwhile, State Street Corp trimmed its position by 381,410 shares, leaving it with 17,069,935 shares valued at around $290 million.

Healthcare Realty Trust Incorporated Stock Up 10.4%

Shares of NYSE:HR recently traded at $20.50. The company has a market cap of about $7.1 billion. Its forward P/E ratio is not meaningful due to negative earnings, but it has a beta of 0.827, indicating lower volatility compared to the broader market. The stock's 52-week range is between $14.92 and $20.90, with a 50-day moving average of $19.40 and a 200-day moving average of $18.12.

12-month forecast

$HR price target

Healthcare Realty Trust Incorporated daily closes and this analyst's $24 target. Not advice.

Insider Buying and Selling at Healthcare Realty Trust Incorporated

In recent insider activity, directors Donald Wood, Thomas Bohjalian, David Henry, Constance Moore, and Glenn Rufrano each purchased 6,683 shares at $20.20 on May 19, 2026. In contrast, President and CEO Peter Scott sold 36,029 shares at $17.84 on April 14, 2026.

About Healthcare Realty Trust

Healthcare Realty Trust Incorporated is a real estate investment trust that specializes in owning and operating medical outpatient buildings. These properties are primarily located near leading hospital campuses across the United States. Headquartered in Nashville, Tennessee, and led by CEO Peter A. Scott, the company manages 579 properties across 28 states, totaling 33.6 million square feet. Healthcare Realty Trust continues to grow its portfolio through strategic acquisitions and development.

Bottom Line

Raymond James' upgrade of Healthcare Realty Trust to a 'buy' rating with a $24 target highlights a renewed confidence in the company's prospects. Investors track such analyst updates for insights into potential stock movements. However, it's important to remember that analyst ratings are based on current information and may not predict future performance accurately.